Nanoparticle News and Research

RSS
Novel mRNA vaccines encoding Monkeypox virus proteins show promise in preclinical studies

Novel mRNA vaccines encoding Monkeypox virus proteins show promise in preclinical studies

OSU researchers develop novel nanomedicine technique for diagnosing and ending ectopic pregnancies

OSU researchers develop novel nanomedicine technique for diagnosing and ending ectopic pregnancies

Well-equipped gut-friendly bacteria hold promise for improving IBD treatments

Well-equipped gut-friendly bacteria hold promise for improving IBD treatments

Nanotechnology platform can make solid tumor cells more receptive to immunotherapy

Nanotechnology platform can make solid tumor cells more receptive to immunotherapy

Mosaic nanoparticles displaying spike protein trimers from different coronaviruses elicits cross-reactive protection

Mosaic nanoparticles displaying spike protein trimers from different coronaviruses elicits cross-reactive protection

IVI and Lemonex sign MOU to join forces on vaccine development

IVI and Lemonex sign MOU to join forces on vaccine development

Biodegradable transport nanoparticle can make anti-inflammatory drug more effective and less toxic

Biodegradable transport nanoparticle can make anti-inflammatory drug more effective and less toxic

A review of vaccines against the respiratory syncytial virus

A review of vaccines against the respiratory syncytial virus

Nebulized mRNA-encoded antibodies found to protect hamsters against COVID-19

Nebulized mRNA-encoded antibodies found to protect hamsters against COVID-19

New research suggests booster dose of Novavax NVX-CoV2373 vaccine is effective against SARS-CoV-2 Omicron subvariants

New research suggests booster dose of Novavax NVX-CoV2373 vaccine is effective against SARS-CoV-2 Omicron subvariants

SpyCatcher-SpyTag technology used to develop recombinant protein-based intranasal vaccine against SARS-CoV-2

SpyCatcher-SpyTag technology used to develop recombinant protein-based intranasal vaccine against SARS-CoV-2

An innovative nasal vaccine strategy to combat COVID

An innovative nasal vaccine strategy to combat COVID

Novel nanotechnology triggers potent therapeutic anti-tumor immune responses against multiple cancers

Novel nanotechnology triggers potent therapeutic anti-tumor immune responses against multiple cancers

The impact of seasonal coronavirus immunity on susceptibility to SARS-CoV-2 infection and  COVID-19 vaccination

The impact of seasonal coronavirus immunity on susceptibility to SARS-CoV-2 infection and COVID-19 vaccination

OSU researchers take major step toward improving, lengthening the lives of cystic fibrosis patients

OSU researchers take major step toward improving, lengthening the lives of cystic fibrosis patients

Advanced type of nanoparticle could help fight hard-to-treat cancers

Advanced type of nanoparticle could help fight hard-to-treat cancers

Collaborative research paves a new way to better health for patients with enlarged hearts

Collaborative research paves a new way to better health for patients with enlarged hearts

Duke biomedical engineers develop a two-pronged approach to treating pancreatic cancer

Duke biomedical engineers develop a two-pronged approach to treating pancreatic cancer

Breakthrough infection risk and immune responses to vaccines associated with human leukocyte antigen alleles

Breakthrough infection risk and immune responses to vaccines associated with human leukocyte antigen alleles

COVID-19 vaccines show favorable immunogenicity and efficacy in people living with HIV

COVID-19 vaccines show favorable immunogenicity and efficacy in people living with HIV

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.